Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Thank You Very Much Phantom. So, I am reading this:
CAR-T works SOMETIMES in SOME cancers, but also sometimes KILLS people, but (as far as I know) Multi-TAA has killed no one.

CAR-T kills B cells so CAR-T patients "require regular infusions of antibodies in the form of immunoglobulin infusions."

Both CAR-T and Multi-TAA both utilize CD4 and CD8 to fight cancer in similar ways.

CAR-T has little to none Epitope spreading, but Epitope spreading is a MAJOR benefit of Multi-TAA.

So having said all that, why is not everybody beating a path to the door of Marker and Multi-TAA.

I guess they are just waiting for more trial data.
Hope it comes soon and continues to be very positive.

I think most of our share price problem is that most of the medical community has never even heard of Multi-TAA.
My Doctor (an internist), and his daughter (an oncologist) never did until I gave them some info on it.

THANKS AGAIN, I always understand better when you translate into plain English.